Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity

Research output: Contribution to journalArticlepeer-review

Abstract

Inhibitors of poly(ADP-ribose) synthetase can be used to prevent neurotoxicity mediated through N-methyl-D-aspartate (NMDA) receptors. Poly(ADP-ribose) synthetase inhibitors can be used therapeutically in the treatment of vascular stroke and neurodegenerative disorders such as Alzheimer's disease, Parkinson's disease and Huntington's disease.

Original languageEnglish (US)
Pages (from-to)771
Number of pages1
JournalBiotechnology Advances
Volume15
Issue number3-4
DOIs
StatePublished - 1997

ASJC Scopus subject areas

  • Biotechnology
  • Bioengineering
  • Applied Microbiology and Biotechnology

Fingerprint

Dive into the research topics of 'Inhibitors of poly(ADP-ribose) synthetase and use thereof to treat NMDA neurotoxicity'. Together they form a unique fingerprint.

Cite this